RxDoctor Payments Data

Tiffany Diament, MD

Psychiatry · Valencia, CANPI 1487997128

Payments from drug & device makers

$1,496in general payments, 2019–2025

Across 76 payments — averaging $19.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$460
  • Otsuka America Pharmaceutical, Inc.$257
  • Johnson & Johnson$255
  • AbbVie$195
  • Neurocrine Biosciences, Inc.$156
  • Vanda Pharmaceuticals Inc.$111
  • plus $62 from 2 others

What the payments were for

  • Food & beverage$1,489100%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,496 in reported general payments places this provider in the 75th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Medicare billing

Part B allowed, 2024
$13,804
Medicare patients
33
Services billed
99

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine24$243,512
Abilify MaintenaAripiprazole20$58,913
Lurasidone Hcl48$20,563
Aripiprazole18$6,173
Risperidone OdtRisperidone12$1,469
Duloxetine Hcl36$1,403
Fluvoxamine Maleate12$1,355
Quetiapine Fumarate74$1,118
Naltrexone Hcl17$1,053
Clozapine26$942
Olanzapine30$764
Fluoxetine Hcl47$714
Bupropion XlBupropion Hcl37$611
Buspirone Hcl43$478
Hydroxyzine Hcl28$445

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$47$243,51224 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$257$58,91320 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,954 psychiatry providers in California.

Other psychiatry in Valencia

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →